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Obesity is common among children and young people, with potential for significant clinical 2 
consequences. The physical and psychological co-morbidities associated with childhood 3 
obesity persist into adult life, but many children do not have access to tailored obesity 4 
services. We present a framework for the identification, assessment, and management of 5 
childhood obesity by the non-specialist. We also offer strategies to initiate discussions about 6 
weight and to communicate effectively with patients living with obesity. 7 
 8 
INTRODUCTION 9 
Childhood obesity is one of the most serious public health challenges of the 21st century, with 10 
rates increasing tenfold over the last forty years. In England, 23% of children starting school 11 
and 34% of children aged 10 to 11 years are classified as overweight or obese. In the UK, 12 
obesity is twice as prevalent in the most deprived populations compared with the least 13 
deprived, while in low-income countries this association is reversed.(1) The definitions of 14 
obesity are listed in Table 1. The development of obesity is complex: societal and economic 15 
factors combined with global trends for increased sedentary behaviours and consumption of 16 
energy-dense food all play a role. 17 
 18 
Childhood obesity leads to adult obesity with increased risk of poor health outcomes and 19 
premature death. Type 2 diabetes and hypertension are increasingly seen in children, and the 20 
psychosocial impact on children’s quality of life includes low self-esteem, depression, and 21 
bullying.(1) Weight bias can lead to lower expectations from teachers, decreased school 22 
attendance, and fewer friends.(1) Perceived benefits of obesity can be a barrier to 23 
intervention and include protection against bullying for some, being seen as a sign of health, 24 
or being valued in some communities. 25 
 26 
This paper aims to support the identification of obesity that requires onward referral: obesity 27 
with suspicion of an underlying cause or with significant co-morbidities. However, as the 28 
majority of obesity is nutritional in origin, this paper also focuses on the assessment and 29 
management of patients whose obesity is not caused by an underlying medical problem. 30 
 31 
Presentation of Childhood Obesity 32 
In the UK, children with obesity may be identified through the National Child Measurement 33 
Programme which records height, weight, and BMI for every child in Reception (age four to 34 
five) and Year 6 (age 10 to 11). Clinicians should also identify obesity opportunistically by 35 
recording and reviewing BMI each time a child is in contact with health services. 36 
 37 
COMMUNICATION  38 
A significant proportion of healthcare consultations are likely to be with children with 39 
overweight or obesity. Neither parents nor healthcare professionals reliably recognise 40 
overweight status in children,(2) limiting the opportunities for acknowledgement and support 41 
towards lifestyle change. Discussing weight status is an area that healthcare professionals 42 
find difficult, citing lack of time or knowledge and concern about preserving patient 43 
relationships. Public Health England’s framework Let’s Talk About Weight uses motivational 44 
interviewing principles to support the person making the behaviour change to identify their 45 
own solutions,(3) and the online Moving Medicine resource (movingmedicine.ac.uk) uses a 46 
similar approach with short conversations tailored to children and young people with obesity. 47 
 48 
Experiences of weight-related stigma can be a barrier to seeking medical attention for 49 
obesity-related concerns, leading to a cycle of disengagement from medical services and 50 
worsening health outcomes. Awareness of language and communication can significantly 51 
change the way that a person with obesity experiences the consultation and increase their 52 
likelihood of engaging with behaviour change.(4) It is particularly important to create a non-53 
judgemental environment, show empathy, and avoid generalisations or assumptions. Further 54 
recommendations are described in Box 1. 55 
 56 
CLINICAL ASSESSMENT 57 
The clinical assessment of the child with obesity focuses on three areas: identifying patients 58 
who require investigation for an underlying cause of obesity, screening for co-morbidities, and 59 
seeking modifiable lifestyle risk factors. 60 
 61 
Identifying patients with a possible underlying diagnosis 62 
Red flags for obesity with an underlying cause include rapid weight gain in infancy, 63 
hyperphagia, and short stature (Table 2). Possible indicators of hyperphagia include waking 64 
at night to eat, demanding food relentlessly, stealing food, eating frozen, dirty or uncooked 65 
food, and disruption of normal daily activities by food-seeking behaviour. Abnormal 66 
development or dysmorphic features may point towards an underlying syndrome. 67 
 68 
Obesity clusters in families, although a family history of severe early onset obesity can point 69 
towards a genetic cause. Short stature should raise suspicion of an endocrinopathy, while 70 
children whose obesity is not caused by an underlying syndrome often have a tendency 71 
towards slightly taller stature than their normal-weight peers until attainment of final adult 72 
height. Small for gestational age infants can show rapid catch-up growth in infancy and 73 
subsequent childhood/adulthood obesity. Puberty in obese children may be earlier than 74 
average but precocious puberty is not expected.  75 
 76 
Genetic testing (available through the University of Cambridge Metabolic Research 77 
Laboratories; www.goos.org.uk) is recommended in patients with extreme obesity before five 78 
years of age, extreme hyperphagia, a family history of extreme obesity, and where bariatric 79 
surgery is being considered.(6, 7) Other investigations may be indicated where there is a 80 
suspicion of a specific underlying cause (Table 2). 81 
 82 
Screening for co-morbidities 83 
Assessment for co-morbidities should be considered in children with BMI ≥98th centile or z 84 
score >2 (Table 3).(5) A family history of type 2 diabetes, cardiovascular disease, or 85 
hyperlipidaemia increases the metabolic risks associated with childhood obesity. Acanthosis 86 
nigricans, an indicator of insulin resistance, is most easily seen at the base of the neck, axilla 87 
or groin. 88 
 89 
Seeking modifiable lifestyle risk factors 90 
In the history, asking about dietary habits, exercise, screen-time, and sleep can help identify 91 
which lifestyle change goals are most suitable for the individual child and family (see Box 2). 92 
A dietary history includes but is not limited to drink preference, snack preference, after-school 93 
eating and eating that takes place during screen-time (“grazing”). A dietary history over the 94 
previous 24 hour period can be useful. It is likewise important to recognise barriers to lifestyle 95 
change that may exist, including financial pressures, limited local availability of fresh food, 96 
and parents/carers who work unsocial hours or who are not able to cook. 97 
 98 
MANAGEMENT 99 
Obesity services in the UK are commissioned in four tiers (Figure 1), with Tier 1 100 
encompassing universal services provided by general practitioners, health visitors and school 101 
nurses. Tier 2 services are commissioned and run by local councils, offering multicomponent 102 
interventions to promote healthy eating habits and physical activity, reduce sedentary time, 103 
and offer behaviour change strategies such as stimulus control and goal setting.(7) Tier 3 104 
services are specialist multi-disciplinary paediatric obesity health services able to offer dietetic 105 
advice, pharmacological management, and, in some centres, psychological support. Supra-106 
specialised Tier 4 services manage patients who are candidates for bariatric surgery. 107 
 108 
Access to services across all tiers varies according to geographical location. Children living in 109 
areas without access to Tier 2 or 3 services may rely on general paediatric or endocrinology 110 
input for management of obesity. Other non-specialists able to support the family include 111 
parenting groups, youth support workers, and family support workers. 112 
 113 
Weight Maintenance vs Weight Loss 114 
In most children who have not yet achieved their final height, weight maintenance rather than 115 
weight loss is advised. However, pre-pubertal children with severe obesity should be 116 
supported to lose weight. Likewise, young people with obesity who have completed growth 117 
should aim to lose weight, usually between 0.5 and 1kg per month.(8) 118 
 119 
Diet and Exercise 120 
Lifestyle advice should focus on both dietary alterations and physical activity (Box 2). Goals 121 
should be realistic and can be revisited on consecutive appointments rather than attempting a 122 
complete lifestyle overhaul at once.  123 
 124 
General principles of the dietary management of obesity in children are the avoidance of 125 
extremely restrictive or “fad” diets and the promotion of sustainable healthy eating patterns. 126 
Although specialist units may offer individualised recommendations (including very low calorie 127 
diets or low carbohydrate/low glycaemic index diets), most general units should provide 128 
dietary advice in line with national guidance (e.g. the UK Eatwell Guide) alongside a 129 
discussion of age-appropriate portion sizes.(9) 130 
 131 
Although a calorie-based approach to weight management is not advocated by the National 132 
Institute for Clinical Excellence (NICE),(5) some families may request advice about 133 
recommended daily calorie consumption for their child. The 2011 Dietary Reference Values 134 
for Energy report details estimated energy requirements by age, sex, and activity levels.(10) 135 
 136 
The benefits of physical activity exceed simple energy expenditure and include improvements 137 
in both physical and mental health. Children between one and four years are advised to 138 
spend 180 minutes of the day physically active.(11) At least 60 minutes per day of moderate-139 
vigorous physical activity (exercising to the point of feeling warmer and breathing faster) is 140 
recommended for school-age children.(11) Advice about physical activity needs to be tailored 141 
to the individual, with consideration of possible mobility limitations or musculoskeletal issues.  142 
 143 
In addition to formal physical exercise, families can explore ways to build more physical 144 
activity into their everyday lives such as walking to school, engaging in active play, or using 145 
stairs rather than lifts and escalators. Screen and sedentary time should also be limited to a 146 
maximum of two hours per day or 14 hours a week.(8) 147 
 148 
Medication 149 
NICE suggests that drug treatment can be considered in children over twelve years with 150 
significant physical or psychological comorbidities under specialist supervision.(5) Drug 151 
treatment under 12 years of age is only considered in the presence of severe comorbidities. 152 
Medications that may contribute to weight loss are listed in Table 4.  153 
  154 
Surgery 155 
Bariatric surgery in young people is effective, leading to clinically significant weight loss and 156 
reduction of type 2 diabetes and other co-morbidities.(12) With concerns about surgical 157 
morbidity and effect on growth and puberty, it is only considered in exceptional 158 
circumstances. Candidates must also have a BMI over 40 (or over 35 with significant co-159 
morbidities) despite all other available management and have reached or nearly reached 160 
physiological maturity.(5, 6) 161 
 162 
Referral to other services 163 
Reduction of BMI is the most effective means of improving obesity-related co-morbidities. 164 
Children with features suggestive of obesity with an underlying cause (Table 2) or evidence of 165 
significant co-morbidities (including sleep apnoea, non-alcoholic fatty liver disease with 166 
significantly or persistently raised ALT,(13) type 2 diabetes) should be referred to the 167 
appropriate specialist service. If significant psychological distress such as anxiety or 168 
depression is identified at any stage, onward referral for psychological support is indicated. 169 
Referral to eating disorders services should be arranged if binge-eating has been identified. 170 
 171 
Safeguarding 172 
A framework for practice published in 2010 suggests that neither obesity nor failure to lose 173 
weight are safeguarding concerns in themselves.(14) However, consistent failure to engage 174 
with services (particularly where there is co-morbidity) or wider concerns about neglect should 175 
prompt safeguarding discussions. 176 
 177 
CONCLUSION 178 
Recognition and management of obesity in children is essential. Consequences of childhood 179 
obesity persist into adulthood and impact physical health, social functioning, and 180 
psychological wellbeing. Communication must be carefully managed, using non-judgemental 181 
language and recognising that families and children may feel apprehensive or defensive 182 
when discussing weight. 183 
In the absence of signs suggesting an underlying cause of obesity, investigations for most 184 
patients focus on the detection and management of clinical consequences of obesity. 185 
Lifestyle change is key, with engagement of the whole family and/or household to support 186 
modification of diet and increased exercise in the long-term. Working together with children, 187 
young people, and their families, paediatricians can play an important role in supporting 188 
changes to promote lifelong health for patients with obesity. 189 
Table 1. Definitions of obesity in children 190 
 WHO(15) UK NICE(5) 
Overweight 
Under five years old:  
Weight/length-for-height 
Z score > 2.0 
Aged 5-19 years: 
BMI Z score > 1.0 
BMI ≥91st centile 
Obese 
Under five years old: 
Weight/length for height 
Z score >3.0 
Aged 5-19 years: 
BMI Z score > 2.0 
BMI ≥98th centile 
Severely obese No universally agreed definition but may be 
described as: 
- severe obesity: BMI >99.6th centile(8) or BMI ≥ 
120% of 95th centile(16) 
- extreme obesity: BMI z score >3.5(13) 
BMI centiles and Z scores 191 
In UK paediatric practice, BMI is usually described in terms of its centile. BMI can also be 192 
described as the number of standard deviations above or below the mean, referred to as the 193 




Reproduced with permission from Obesity UK. Available from: https://cdn.easo.org/wp-198 
content/uploads/2020/07/31073423/Obesity-Language-Matters-_FINAL.pdf 199 
 200 
Table 2. Underlying causes of obesity 201 
 202 
Cause Suggestive features 
Endocrinopathy 
 
Children with an endocrinopathy demonstrate poor linear 
growth and short stature (relative to mid-parental height and 
target centile range) in combination with overweight/obesity. 
 Hypothyroidism Hypothyroidism can contribute to weight gain, but note that 
a mildly raised TSH (<10 mIU/L) is common in obesity. In 
the absence of positive thyroid peroxidase antibodies and 
with a normal FT4, isolated mild raised TSH is not 
suggestive of hypothyroidism and treatment is not 
recommended.(17)  
 
 Cushing’s syndrome Arrested growth is a key feature. Associated features such 
as a short history of obesity, rapid weight gain, lack of family 
history and virilisation may also be present.  
Genetic 
 
Children with genetic causes of obesity typically have early 
onset of severe obesity, with rapid weight gain in infancy. 
Syndromic and monogenic causes should be considered.  
 Syndromic obesity Includes Prader-Willi syndrome, Bardet-Biedl syndrome. 
Additional syndromic features such as hypotonia, poor 
feeding in infancy and learning difficulties may be present. 
 Monogenic obesity Includes melanocortin 4 receptor deficiency and leptin 
deficiency. Associated features such as severe 
hyperphagia, developmental delay, sensorineural deafness, 
abnormalities of the eyes, hypoglycaemia or intestinal 
dysfunction may suggest a monogenic cause. 
 
 Polygenic obesity Many single nucleotide polymorphisms have a very small 
effect on an individual’s predisposition to 
overweight/obesity. Each variant present adds to an 
individual’s cumulative risk of obesity. 
 203 
Table 3. Screening for co-morbid conditions 204 
Co-morbid condition Investigation 
Hypertension Diagnose hypertension if serial measurements with an 
appropriately sized cuff (ideally including manual 
measurements) are ≥ 95th centile for age, sex, and height OR if 
the blood pressure is ≥ 130/80 in children aged 13 and over. 
Box 1. Talking about obesity and overweight with children and young people 
• Young people, and the adults with them, may be concerned to hear they have obesity or are 
overweight. Listen to these concerns first, before giving any advice.  
• If you do provide advice, collaborate with young people and/or the adults with them. Do not make 
assumptions about their behaviours, and invite their input and thoughts. 
• Statements like “other young people have said x” or “some young people say y” can help you 
show the person that they are not alone. 
• Some statements may imply blame for either the young person, or the adult with them. Think 
carefully about focusing on small positive changes, rather than negatively commenting on current 
behaviours. 
 
Adverse lipid profile If abnormal fasting LDL/HDL and cholesterol, can prompt 
personalised discussions about the health consequences of 
obesity and support dietetic input. In the absence of familial 
hypercholesterolaemia, pharmacological treatment of 
hyperlipidaemia is unusual in young people but should be 
considered. 
Type 2 diabetes and 
insulin resistance 
HbA1c values of ≥48 mmol/mol indicate diabetes. 
Fasting insulin and glucose can be used to gauge insulin 
resistance by the HOMA score.  
 
Fasting plasma glucose (mmol/L) × fasting plasma insulin 
(mU/L) / 22.5 
 
Patients with a HOMA score ≥4.5,(13) signs or symptoms of 
insulin resistance, an HbA1c of 42-47 mmol/mol, or considered 
high risk should undergo a full oral glucose tolerance test. 
Non-alcoholic fatty liver 
disease (NAFLD) 
Children with severe NAFLD are likely to have a raised alanine 
transaminase (ALT). Mild NAFLD may present with normal liver 
function tests and only be detectable on imaging including 
elastrography. 
Sleep apnoea Consider sleep apnoea in children with a history of nocturnal 
gasping, snoring, or frequent waking alongside daytime 
somnolence, headache, and difficulty concentrating. Poor 
quality sleep also negatively impacts daytime lifestyle. 
Polycystic ovary syndrome 
(PCOS) 
PCOS should be diagnosed with caution: mild hirsutism and 
menstrual irregularities are common in adolescence. Consider 
PCOS where there is clinical and biochemical evidence of 
hyperandrogenism alongside menstrual irregularities. 
Psychological distress Ask about friendship groups, bullying, mood, and self harm. 





Table 4. Pharmacological management of obesity in children and young people 210 
Medication Clinical effectiveness Important side effects 
Orlistat 
Licenced in Europe and 
USA ≥12 years of age for 
specialist use 




symptoms: diarrhoea, urgency, 
abdominal pain, oily/fatty stool 
Side effects are milder with low 
fat diets 
Liraglutide 
Licenced in Europe and 
USA for treatment of type 2 
diabetes in children ≥10 
years old 
Licensed in USA for weight 
management aged ≥12 
years old 
Approximately 5% of 
body weight lost 
(approximately 4.5kg 
weight loss in paediatric 
trials) (19) 
Nausea and diarrhoea 
Risk of diabetic ketoacidosis in 
patients with type 2 diabetes 
treated with insulin and 
liraglutide 
Metformin 
Licenced in Europe and 
USA for treatment of type 2 
diabetes in children ≥10 
years old 
Not specifically licenced for 
weight management 
Average weight loss in 
clinical trials in children 
is 3-4kg(20) 
Mild gastro-intestinal side effects 
(nausea, abdominal pain), which 
usually improve spontaneously 
after several weeks 
Side effects reduced by initiation 
at a low dose followed by 








Box 2. Brief suggestions for weight management goal-setting  
Dietary changes  
Limit snacking, grazing and food between main meals  
Increase vegetable and fruit intake (at least five portions a day)  
Eliminate or reduce soft drinks and fruit juices  
Pay attention to age-appropriate portion sizes – try smaller plates 
Reduce frequency of take-aways and ready meals  
Avoid keeping energy-dense food at home (e.g. biscuits, sweets, chocolate, crisps)  
Discourage second helpings  
Have regular family mealtimes and avoid combining meals with screen time  
Recognise cues for snacking (e.g. boredom, stress)  
Slow the pace of eating to allow time for satiety signals to develop  
Advise parents/carers to avoid using food as a reward 
 
Exercise/activity  
Use active transport to get to and from school (walk, cycle, scoot)  
Plan physical activity as a family e.g. weekend cycles or walks  
Decrease sedentary and screen time  
Join sports clubs or training sessions  
 
Other  
Encourage good sleep hygiene  
  
Children/families can choose 2-3 of these goals to focus on at a time. Management is 
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